Communiqués

12/05 Canadian Investment Regulatory Organization Trading Halt - XCX AQ
08/08/22 Greenrise Announces Record Sales for Q2 and Comments on Positive Developments regarding the Legislation of Adult-Use Cannabis in Germany AQ
20/06/22 Greenrise Provides Update on CannaCare's Sales Growth and First Quarter Results AQ
11/05/22 Greenrise Announces Appointment of Frank Otto to the Board of Directors and Closing of the Acquisition of Control of CannaCare Health GmbH AQ
05/04/22 /R E P E A T -- Greenrise Advances its Leadership Position in Germany with the Acquisition of a Majority Interest in CannaCare Health GmbH and the Appointment of Frank Otto to its Board of Directors/ AQ
05/04/22 Greenrise Advances its Leadership Position in Germany with the Acquisition of a Majority Interest in CannaCare Health GmbH and the Appointment of Frank Otto to its Board of Directors AQ
12/01/22 Greenrise Global's Medical Cannabis Subsidiary, AMP Alternative Medical Products GmbH Announces the Beginning of Dronabinol Sales in Germany AQ
22/12/21 Greenrise Global: Year-end Letter to the Shareholders AQ
25/11/21 /R E P E A T -- Greenrise Global's Supports Germany's Approach to Cannabis Legalization for Adult Use/ AQ
25/11/21 Greenrise Global's Supports Germany's Approach to Cannabis Legalization for Adult Use AQ
23/11/21 /R E P E A T -- Greenrise Global Launches Herbify CBD Wellness Brand in Germany/ AQ
23/11/21 Greenrise Global Launches Herbify CBD Wellness Brand in Germany AQ
17/11/21 /R E P E A T -- Greenrise Global's Medical Cannabis Subsidiary Announces the Introduction of its Dronabinol Product to the German Market/ AQ
17/11/21 Greenrise Global's Medical Cannabis Subsidiary Announces the Introduction of its Dronabinol Product to the German Market AQ
05/11/21 CSE Bulletin: Name Change - AMP Alternative Medical Products Inc. (XCX) NE
03/11/21 /R E P E A T -- AMP Announces Strategic Acquisition of German CBD Wellness Company and Leading Cannabis Executive Team/ AQ
03/11/21 AMP Announces Strategic Acquisition of German CBD Wellness Company and Leading Cannabis Executive Team AQ
28/09/21 AMP Alternative Medical Products : R E P E A T -- AMP Becomes Exclusive Marketing Partner of Tilray for Aphria Medical Cannabis Brand in Germany/ AQ
28/09/21 AMP Alternative Medical Products : Becomes Exclusive Marketing Partner of Tilray for Aphria Medical Cannabis Brand in Germany AQ
13/09/21 AMP Alternative Medical Products : R E P E A T -- AMP Alternative Medical Products and Waldhausklinik Deuringen Announce Clinical Study into the Effects of Medical Cannabis/ AQ
13/09/21 AMP Alternative Medical Products : and Waldhausklinik Deuringen Announce Clinical Study into the Effects of Medical Cannabis AQ
08/09/21 AMP Alternative Medical Products : R E P E A T -- AMP Launches its CBD Brand, CANAVEX® at YES!CON, Germany's Largest Cancer Convention/ AQ
08/09/21 AMP Alternative Medical Products : Launches its CBD Brand, CANAVEX® at YES!CON, Germany's Largest Cancer Convention AQ
07/07/21 /R E P E A T -- AMP Alternative Medical Products: President's Half-Year Letter to Shareholders/ AQ
07/07/21 AMP Alternative Medical Products: President's Half-Year Letter to Shareholders AQ
Aucun résultat pour cette recherche